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1. Introduction 
As an alternative to hypotheses of eukaryotic gene 
regutation which involve the association of DNA and 
regulatory molecules, I wish to propose a model 
involving the specific binding of regulatory molecules 
to messenger RNA precursors (ore-mR~A) to control 
rates of differential gene transcription. This model, 
based on that of Lee and Yanofsky [ 1] for the trp 
operon ofEsckeri&ia coli,emphasizes the importance 
of the noncoding ‘leader’ sequences at the 5’.termini 
of eukaryotic pre-mRNAs in the ‘attenuation of 
tralls~riptio~l. According to the model, the secondary 
and/or tertiary structure at the S’-end of the nascent 
pre-mRNA determines the degree of early transcrip- 
tion termination. Formation of a specific termination 
complex will result in the abortive arrest of transcrip- 
tion and release of uncompleted, nascent transcripts 
from the template, A modulation of the secondary or 
tertiary structure at the .5’-end of the pre-mRNA by 
specific regulatory molecules (antiattenuators) which 
bind to the pre-mRNA would alter the degree of early 
transcription termination and result in antiattenua- 
tion. Antiattenuation would consequently involve a 
change in the el(~ngation efficiency of transcription 
and in the overall rate of transcription (fig.1). This 
model, and its elaborations, can be used to explain a 
number of disparate experiments on gene transcrip- 
tion and regulation in eukaryotes. 
ft is now evident that in eukaryotic cells differen- 
tial gene tr~scr~ption is one major regL~lato~ step in 
a hierarchy of controls which also includes processing 
ofmRNAprecursors and selective transport of mRNA 
E(sevierlNortlr-I~~l~and Biomedical Press 
sequences to the cytoplasm [2,3]. Recent studies 
show that processing of the pre-nlRNA involves exci- 
sion of noncoding intervening sequences and splicing 
together of the coding sequences [4,5]. The pre-mRNA 
Fig. I. Schema of attenuation and ant~attetl~tion i eukaryotic 
nuclei according to the model described in the text. RNA 
polymerase (0); antiattenuator molecule (a). Changes in the 
confo~~nation f the RNA are indicated by the loop. Attenua- 
tion (a): nonspecific initiation of transcription can result in 
early transcription termination and the release of abortive 
transcripts (a,c). A certain percentage of transcription read- 
through (d) will nevertheless occur whereby complete, 
thou& not necessarily functional, transcripts are formed. 
This readthrough may result in a nonfunctional, ‘non-pre- 
mRNA” population described by Wold et al. [47]. Anti- 
attenuation (b): Initiation of transcription is followed by 
the binding of regulatory molecules, termed antiattenuators, 
to the nascent pre-mRNA. The resulting modulation of the 
conformat~an of the transcript near its 5~-terrn~us will 
prohibit the formation of the transcription-termination 
complex. Active transcription (e) will ensue. 
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also contains a 5’ noncoding leader sequence and a 
3’ noncoding sequence, both of which are retained in 
the functional mRNA molecule [6,7]. 
In the past decade supporting evidence for specific 
differential tr~scription as the central nlechanism of 
gene expression in eukaryotes has come primarily from 
chromatin transcription studies in vitro and from the 
measurement of RNA sequence complexity in vivo. 
A number of regulatory schemes [S-l 0] modeled to 
varying extents after the lac operon of E. coli have 
been proposed in which the initiation of gene tran- 
scription is specified by regulatory molecules. Some of 
these modelshave been shown to be genetically unrea- 
sonable [ 111. It has been claimed that the in vitro 
transcription of tissue-specific RNA from chromatin 
reconstituted in the presence of tissue-specific, non- 
histone nuclear proteins (NHCPs) provides evidence 
for the central role of specific initiation of gene tran- 
scription and for the importance of NHCPs in the 
regulation of eukaryotic gene expression [ 12-141. 
It is now known, however, that these studies have 
been complicated generally by the fact that exogenous 
E. coil RNA polymerase was used; this enzyme tran- 
scribes from tissue-specific RNA contaminating the 
chromatin preparations [IS]. The more recent experi- 
ments cast serious doubt upon the validity of inter- 
pretation of the earlier in vitro transcription experi- 
ments (reviewed in [ 161). Zazloff and Felsenfeld [IS J 
have shown that there is, in fact, little or no differ- 
ential transcription of mRNA globin sequences when 
reticulocyte chromatin is transcribed in vitro using 
mercurated nucleotides. On the other hatid, Towle 
et al. f17], using the oviduct system with mercurated 
nucleotides, found a stimulation of transcription in 
vitro of the ovalbumen sequence after estrogen 
administration. But the preferential transcription was 
only lo-times more than oviduct globin gene tran- 
scription and only 4-times more than ovalbumen gene 
transcription from reticulocyte chromatin. Other 
studies of transcription in vitro and in vivo show a 
stimulation of tissue-specific transcription after 
hormone treatment of only about 1 order of mag 
nitude [l&20]. 
The more recent measurements of pre-mRNA 
sequence complexity in vivo by RNA-DNA hybridiza- 
tion studies are also consistent with the in vitro data 
indicating relatively small transcriptional changes 
during induction of gene expression. Nuclear RNAs 
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transcribed from the (gene-containing) single-copy 
DNA of different embryonic stages of sea urchins 
have practically the same sequence complexities at 
times when cytoplasmic sequence complexities are 
very different [Z l]. Transcriptional differences 
between different stages of the mammalian cell 
cycle may also be less itnportant [22] than sup- 
posed [23]. Measurements of sequence complexity 
of the nuclear RNA (pre-mRNA) transcribed from 
single-copy DNA of different tissues are revealing 
an interesting pattern of traliscriptional differences. 
Nuclear RNA sequences are extensively shared 
between different tissues [24-281. Chikaraishi 
et al. [27] have found that mixtures of nuclear RNAs 
from different tissues, which are simultaneously 
annealed to single-copy DNA, hybridize to the same 
extent as the more complex of the RNA preparations 
isolated from one of the tissues. For instance, all kid- 
ney sequences (i.e., > 95%) are found among the more 
complex liver sequences, and all liver sequences (i.e., 
> 94%) are found among the yet more complex popula- 
tion of brain sequences. The least abundant RNAs 
possess the greatest sequence complexity. In fact, the 
average frequency of occurrence of each nonrepetitive 
nuclear RNA is under one (0.07- 1 .O) copy per cell 
[21,27,2&]. The frequency distribution of hetero- 
geneous nuclear (hn) RNA abundance classes is not 
the same for different tissues [25-271. Also, tran- 
scriptional stinlulation or i~~hibition in a single cell 
type may change the frequency distributions of 
classes of pre-mRNA molecules [29]. However, no 
large changes over 2 or 3 orders of magnitude, such 
as seen with some bacterial operons, and no pattern 
of complete disappearai~ce of primary transcripts 
have been demonstrated in eukaryotic somatic cells. 
The above data are part of an accumulating body of 
evidence which indicates that transcriptional dif- 
ferences between cells of different tissues, develop- 
mental or cell-cycle stages, or hormonal states may 
be quantitative more than qualitative. It is quite 
possible that no specific or stringent ‘turning on’ 
(initiation) or ‘turning off (repression of initiation) 
of specific genes occurs at the level of transcription 
in somatic cells of eukaryotes. 
2. Attenuation in bacteria and eukaryotes 
The attenuation model of gene regulation pro- 
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posed here is cotranscriptional in that a modulation 
of secondary and/or tertiary structure of the 5’-ter- 
minus of the pre-mRNA by antiattenuator molecules 
which bind to the pre-mRNA accounts for changes _ 
in the rate of transcription of selected genes. Attenu- 
ator sequences and leader RNAs involved in early 
transcription termination have been demonstrated 
in several bacterial operons [30-331. Lee and 
Yanofsky [l] have proposed a model in which the 
stability of the secondary structure at the 3’-end of 
the leader sequence of mRNA influences transcrip- 
tion. In its simplest form their model proposes that 
the rate of ribosome movement along the RNA will 
shift the RNA intramolecular base configurations and 
effect the ‘stem and loop’ secondary structures, either 
allowing (rapid ribosome movement) or prohibiting 
(ribosome arrest or slow ribosome movement) the 
formation of termination complexes. There is a 
certain frequency of readthrough of transcription 
beyond the termination site under conditions which 
normally would be expected to result in transcription 
termination. (Transcription readthrough is also a 
feature of the eukaryotic model introduced here.) The 
readthrough frequency can be quite variable (from 
576%) depending upon the operon, bacterial species, 
and presence of mutations in the attenuator sequence 
[ 1,30,3 I]. Single base-pair alterations in the E. coli 
trp operon leader region, which destabilize ‘stem and 
loop’ structures, relieve transcription termination at 
the trp attenuator [31]. The rate of ribosome move- 
ment and ribosome arrest are determined, in turn, by 
levels of certain charged tRNAs (for instance, charged 
tRNATm for the trp operon). Some mutations that 
decrease the levels of specific, charged tRNAs by 
15-60% have a 3-lo-fold effect on gene expression 
apparently by affecting attenuation [32]. 
There are several differences between the bacterial 
model and the eukaryotic model proposed here (fig. 1). 
There is no coupling of transcription and translation 
in eukaryotic cells as in bacterial cells. Consequently, 
ribosome movement and arrest cannot modulate 
attenuation. Instead, antiattenuation must be directed 
by the binding to pre-mRNA of other regulatory 
molecules, termed antiattenuators, which are either 
protein, RNA or some combination of the two species 
of molecules. It is likely that the antiattenuator has a 
protein component. It is known that NHCPs and 
hormone receptors, which are proteins, can have a 
direct effect on transcription [ 14,341. There is, 
additionally, a body of evidence which suggests that 
small, nuclear RNA species may be implicated 
directly in gene transcription [35-411. The binding 
of the antiattenuator need not necessarily occur at 
the 5’-terminal leader sequence of the pre-mRNA. 
However, the binding is pictured as occurring primarily 
at the 5’-terminus for the sake of clarity and economy 
(fig.1). 
An ancillary, post-transcriptional feature of this 
model is the proposition that the binding of the pre- 
mRNA to the small ribosomal subunit would require 
an appropriate, accessible conformation at the 5’ 
ribosome binding site of the pre-mRNA. A modula- 
tion of the 5’ leader conformation would theoretically 
change the ability of the small ribosomal subunit to 
bind to the pre-mRNA. According to the model, there- 
fore, another function of antiattenuator molecules, 
in modulating secondary and tertiary structure, may 
be the induction of a specific conformation enabling 
attachment to the small ribosomal subunit. Messenger 
sequences would thus be selected from the mass of 
hnRNA for ribosome binding. Hydrogen bonding of 
a sequence near the 5’-terminus of messenger RNA to 
a complementary sequence near the 3’-terminus of 
the 18 S ribosomal RNA has been suggested as a 
mechanism of ribosome attachment [42]. An impres- 
sive degree of such complementarity has been shown 
to exist for some, but not all, eukaryotic messages 
[43]. The proposition here is that it is not the primary 
sequence which is directly recognized for attachment 
but a specific secondary or tertiary conformation 
induced by the binding of an antiattenuator. Thus, a 
common mechanism may account for relief of abortive 
transcription termination and for the selection of 
messenger sequences for ribosome attachment. Anti- 
attenuation of transcription and ribosome binding 
may be coupled to modulation of the same secondary 
and tertiary structure on the pre-mRNA. On the other 
hand, very different binding sites for the antiattenua- 
tion of transcription and the facilitation of ribosome 
attachment could exist, in which case the two phenom- 
ena would not be coupled. 
3. Discussion 
Attenuation and antiattenuation in eukaryotes is 
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presented here as a major regulatory step in a hierarchy 
of controls by which genes are differentially expressed. 
To what extent does the attenuation model of tran- 
scriptional regulation account better for the eukaryotic 
transcription data than existing operon-like, initiation 
models? Several points can be made. The attenuation 
model better explains the quantitative data. Relief 
of early transcription termination in bacteria generally 
results in transcriptional differences of 5-20-fold. As 
mentioned, this is the order of magnitude of the 
transcriptional differences observed in eukaryotic 
systems upon induction of gene expression. 
A certain amount of nonspecific transcription 
readthrough is predicted by the model. Transcription 
readthrough of normally attenuated sequences can 
account for the very extensive overlapping of sets of 
transcribed sequences between different tissues and 
embryonic stages [21,26,27]. Transcription read- 
through is also a cogent explanation for the very 
low frequency of occurrence of most of the hnRNA 
and pre-mRNA [21,26,27]. Therefore, most of the 
sequence complexity of heterogeneous nuclear RNA 
observed in eukaryotes may be a consequence of such 
nonspecific transcription readthrough. 
Early transcription termination (attenuation) would 
normally result in the formation of small abortive 
transcripts in the nucleus. If the termination complex 
were slowly released from the DNA template, a sub- 
stantial part of this RNA might associate with the 
chromatin. The existence of low molecular weight 
‘cRNA’ [44] hybridizing to a relatively large portion 
of the genome has been observed in a number of 
laboratories. It is possible the ‘cRNA’ is composed, 
to a large extent, of the products of early transcrip- 
tion termination rather than random breakdown prod- 
ucts of hnRNA as suggested [45]. At times of active 
gene expression one might expect a diminution of 
such abortive transcription and a significant increase 
in the average length of the primary transcripts. 
If the proposed model is correct, one would also 
expect to observe changes in the efficiency of attenua- 
tion by incorporation into RNA ofbase analogs which 
alter normal hydrogen bonding and consequently alter 
secondary structure. An increased efficiency of atten- 
uation would be indicated by a decrease in the forma- 
tion of large hnRNA molecules without a correspond- 
ing decrease in the formation of low molecular weight, 
attenuated RNA sequences. This is exactly what is 
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found when the RNA synthesis inhibitor (an adenosine 
analog), 5,6-dichloro-I-P-D-ribofuranosylbenzimidazolc 
(DRB) is administered to Hela cells [46]. The synthe- 
sis of RNA in the size-range of 140.-740 bases catal- 
yzed by RNA polymerase II is relatively unaffected 
by DRB while hnRNA synthesis is rapidly reduced 
by 66%. The ‘resistant’ hnRNA synthesis may repre- 
sent a continued, though reduced, transcription read- 
through. DRB also inhibits>95%ofmRNA synthesis. 
This implies, in addition, that the antiattenuator 
molecules are no longer effective in selectively pre- 
venting the attenuation (abortive transcription) of 
active genes. The site of action of DRB is evidently 
distal to the initiation point of RNA synthesis [46]. 
Antiattenuation during induction of gene expres- 
sion should cause changes in the frequency distribu- 
tion of classes of nuclear RNA. Such changes have 
been observed [29]. An increase in the length of 
specific pre-mRNA has. in fact, been observed during 
estrogen enhancement of vitellogenin sequence tran- 
scription in chick liver [ 181; a dramatic increase in 
the length of the primary transcript formed in vitro 
using a homologous RNA polymerase II coincided 
with a 13-fold increase in vitellogenin transcript 
accumulation. More experiments of this genre should 
be performed to determine whether transcript elonga- 
tion is a general phenomenon during eukaryotic gene 
activation. 
The hypothesis presented here, modeled after atten- 
uation of gene transcription in bacteria, does not 
postulate any cumbersome mutational events. The 
points emphasized in the model can be tested experi- 
mentally. The model has heuristic value in that it 
would account for and integrate much hitherto unex- 
plained experimental data on gene transcription. 
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